Benign prostatic hyperplasia in primary care: What you need to know

被引:49
作者
Burnett, AL
Wein, AJ
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Penn, Hlth Syst, Philadelphia, PA 19104 USA
关键词
prostate; benign prostatic hyperplasia; bladder neck obstruction; urination disorders;
D O I
10.1016/S0022-5347(05)00310-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We reviewed recent literature and treatment guidelines regarding the prevalence, pathophysiology, and management of BPO related to BPH; and management of lower urinary tract symptoms secondary to BPH. Materials and Methods: Published literature and current treatment concepts were reviewed regarding the diagnosis and treatment options for BPO. Results: BPH is a histological diagnosis that can contribute to medical problems, including enlargement of the prostate and BPO. These conditions should be treated only if the symptoms are troublesome, there is considerable risk of progression, and/or cancer is suspected. Very effective medical and surgical options are available to treat BPO and improve patient quality of life. Conclusions: BPO is highly treatable, but should be managed in close collaboration with the patient. Pharmacological agents and minimally invasive procedures, when appropriate, are generally preferred to more invasive surgery. Patients with mild or moderate symptoms usually can be treated by a primary care physician; more complicated cases should be referred to a urologist for evaluation and management.
引用
收藏
页码:S19 / S24
页数:6
相关论文
共 27 条
[1]  
*ABB LAB, 2001, HYTR PACK INS
[2]  
Abrams P., 2001, Neurourology and Urodynamics, V20, P547
[3]   RESULTS OF PROSTATECTOMY - SYMPTOMATIC AND URODYNAMIC ANALYSIS OF 152 PATIENTS [J].
ABRAMS, PH ;
FARRAR, DJ ;
TURNERWARWICK, RT ;
WHITESIDE, CG ;
FENELEY, RCL .
JOURNAL OF UROLOGY, 1979, 121 (05) :640-642
[4]  
Appell Rodney A, 2003, Rev Urol, V5 Suppl 8, pS37
[5]   Combination treatment with an α-blocker plus an anticholinergic for bladder outlet obstruction:: A prospective, randomized, controlled study [J].
Athanasopoulos, A ;
Gyftopoulos, K ;
Giannitsas, K ;
Fisfis, J ;
Perimenis, P ;
Barbalias, G .
JOURNAL OF UROLOGY, 2003, 169 (06) :2253-2256
[7]  
BARTSCH G, 2001, BENIGN PROSTATIC HYP
[8]  
*BOEHR ING PHARM, 2004, FLOM PACK INS
[9]  
CHATELAIN C, 2001, BENIGN PROSTATIC HYP
[10]   Long-term risk of re-treatment of patients using α-blockers for lower urinary tract symptoms [J].
De La Rosette, JJMCH ;
Kortmann, BBM ;
Rossi, C ;
Sonke, GS ;
Floratos, DL ;
Kiemeney, LALM .
JOURNAL OF UROLOGY, 2002, 167 (04) :1734-1738